tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Naz Rahman, 40 are a BUY (85.11%), 7 are a HOLD (14.89%).
Analyst Naz Rahman, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 21.11% that have a potential upside of 34.35% achieved within 167 days.
Naz Rahman’s has documented 81 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 18-Mar-2026.
Analyst best performing recommendations are on VKTX (VIKING THERAPEUTICS).
The best stock recommendation documented was for VKTX (VIKING THERAPEUTICS) at 12/19/2022. The price target of $15 was fulfilled within 99 days with a profit of $8.01 (114.59%) receiving and performance score of 11.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Oct-2021
$3
4 years 1 months 14 days ago
(23-Aug-2022)
0/2 (0%)
$2.55 (566.67%)
Hold Since 22-Aug-2022
$13
4 years 1 months 15 days ago
(22-Aug-2022)
0/1 (0%)
$8.7 (202.33%)
Buy Since 14-Oct-2021
$10
4 years 4 months 20 days ago
(17-May-2022)
0/1 (0%)
$4.78 (91.57%)
Buy Since 20-Sep-2021
$12
$11.98 (59900.00%)
5 years 17 days ago
(20-Sep-2021)
0/1 (0%)
$3.86 (47.42%)
Buy Since 20-Sep-2021
$20
$19.98 (99900.00%)
5 years 17 days ago
(20-Sep-2021)
0/1 (0%)
$11.86 (145.70%)
What Year was the first public recommendation made by Naz Rahman?
